1. Fresán, Ujué, Rodríguez-Sánchez, Maria A, Reina, Oscar, Corces, Victor G, Espinàs, M Lluisa. 2020. Haspin kinase modulates nuclear architecture and Polycomb-dependent gene silencing. In PLoS genetics, 16, e1008962. doi:10.1371/journal.pgen.1008962. https://pubmed.ncbi.nlm.nih.gov/32750047/
2. Tanaka, Hiromitsu, Tokuhiro, Keizo. 2022. A Haspin promoter element induces tissue-specific methylation of a transcription region and the regulation of gene expression in mouse ova. In Cell journal, 24, 552-554. doi:10.22074/cellj.2022.8444. https://pubmed.ncbi.nlm.nih.gov/36274209/
3. Zhu, Dawei, Gu, Xing, Lin, Zhenyu, Wang, Jing, Li, Li. 2020. HASPIN is involved in the progression of gallbladder carcinoma. In Experimental cell research, 390, 111863. doi:10.1016/j.yexcr.2020.111863. https://pubmed.ncbi.nlm.nih.gov/31987787/
4. Maeda, Naoko, Tsuchida, Junji, Nishimune, Yoshitake, Tanaka, Hiromitsu. 2022. Analysis of Ser/Thr Kinase HASPIN-Interacting Proteins in the Spermatids. In International journal of molecular sciences, 23, . doi:10.3390/ijms23169060. https://pubmed.ncbi.nlm.nih.gov/36012324/
5. Wang, Peiling, Hua, Xiangmei, Bryner, Yuge Han, Gitter, Christopher B, Dai, Jun. 2019. Haspin inhibition delays cell cycle progression through interphase in cancer cells. In Journal of cellular physiology, 235, 4508-4519. doi:10.1002/jcp.29328. https://pubmed.ncbi.nlm.nih.gov/31625162/
6. Tanaka, H, Iguchi, N, Nakamura, Y, de Carvalho, C E, Nishimune, Y. . Cloning and characterization of human haspin gene encoding haploid germ cell-specific nuclear protein kinase. In Molecular human reproduction, 7, 211-8. doi:. https://pubmed.ncbi.nlm.nih.gov/11228240/
7. Wang, Peiling, Hua, Xiangmei, Sun, Yang, Hsung, Richard P, Dai, Jun. . Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21923. doi:10.1096/fj.202100099R. https://pubmed.ncbi.nlm.nih.gov/34551143/
8. Xu, Chenyue, Gao, Qiongmei, Wu, Zhengming, Wang, Nianhong, Li, Qingquan. 2022. Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas. In Translational oncology, 26, 101540. doi:10.1016/j.tranon.2022.101540. https://pubmed.ncbi.nlm.nih.gov/36115073/
智鼠故事 
